Piramal Pharma slipped 1.14% to Rs 195.40 after the US FDA issued a Form-483 with 6 observations to the company's Turbhe facility post a GMP inspection.

Piramal Pharma shares will be in focus after the US FDA's GMP inspection at its Turbhe facility from February 11-17, 2025, ...

The observations are mainly procedural and do not indicate any data integrity issues, Piramal Pharma added in a regulatory ...

The company stated that the observations primarily pertain to procedural improvements and are not related to data integrity.

IST, the barometer index, the S&P BSE Sensex, slipped 287.76 points or 0.38% to 75,679.63. The Nifty 50 index declined 92.15 points or 0.40% to 22,853.15.

The company's Q3FY25 consolidated profit plunged 63.6 percent to Rs 3.68 crore versus Rs 10.1 crore, while revenue rose 12.5 ...

Shares of firms like Vedanta, Tata Steel, RVNL, Max Healthcare, Allcargo Gati, and others will be in focus on Wednesday's ...

Piramal Pharma's Turbhe facility in Navi Mumbai receives six observations from U.S. FDA inspection, company preparing detailed response.

Stocks like Indian Overseas Bank, Larsen & Toubro, Container Corporation of India, Cello World, RBM Infracon, Bharti Airtel, Voler Car, PS Raj Steels, and Maxvolt Energy Industries will be in focus on ...

Here’s a quick look at stocks likely to be in focus in today's trade. Tata Steel: Tata Steel Ltd announced that the Neath ...

Indian benchmark indices ended lower and posted mild cuts on Tuesday amid persistent FII selling and falling rupee. BSE ...

Track Infosys, L&T, and Tata Steel today for key market shifts. Explore big deals and latest updates in stocks!